Physical Address

304 North Cardinal St.
Dorchester Center, MA 02124

These FDA-Approved Drugs and Vaccines Were ‘Most Influential’ in 2024: GoodRx


Join Fox News to access this content

Plus special access to selected articles and other premium content with your account – for free.

By entering your email address and clicking Continue, you agree to Fox News Terms of use and Privacy Policywhich includes ours Notice of financial incentives.

Please enter a valid email address.

2024 brought important results advances in medicine.

This includes the approval of “innovative” drugs such as Tryvio for high blood pressure, Neffy for severe allergic reactions and Dupixent for chronic obstructive pulmonary disease (COPD), all of which received FDA approval this year.

These medicines “are set to have a major clinical impact on those who need them,” according to GoodRx, a California-based digital health platform.

WHAT ARE PRESCRIPTION DRUGS CALLED? A DRUG DEVELOPMENT EXPERT SHARES THE PROCESS

Earlier this month, GoodRx released a list of the 19 most influential drugs and vaccine permits 2024, some newly developed to treat certain diseases and other existing drugs that have been approved for additional use.

A scientist uses a microscope to analyze in a laboratory

GoodRx created its list by prioritizing “first-in-class drugs and vaccines that are expected to make a significant impact on human health.” (iStock)

Here is a list in order of FDA approval date.

1. Dupixent – Additional uses: eosinophilic esophagitis (an allergic condition that causes inflammation of the esophagus)

2. Amtagvi – New medicines: Advanced melanoma

3. Xolair – Additional use: Food allergy

THE 7 TOP QUESTIONS TO GOOGLE ABOUT HEALTH IN 2024 WITH ANSWERS OF EXPERTS

4. Vegs – Additional uses: Reduction of cardiovascular risk

5. Trivia – New medications: high blood pressure

6. Nexletol – Additional uses: high cholesterol

Close-up of hands stacking medication in daily pill organizer

Some drugs offer new treatments for common conditions, such as Tryvio for high blood pressure and Nexletol for high cholesterol. (iStock)

7. Winrevair – New drug: pulmonary arterial hypertension

8. mRESVIA – New vaccine: RSV

9. Capvaxive – New vaccine: Pneumococcal disease

10. Vakiks – Additional use: pediatric narcolepsy

5 MAIN DISCOVERIES BY SCIENTISTS IN 2024.

11. It is dangerous – New medicines: COPD

12. Kitty – New medicines: Alzheimer’s disease

13. Visually – Additional use: Heartburn from non-erosive GERD (gastroesophageal reflux disease)

A healthcare worker prepares a vaccine injection or treatment

Some newly approved drugs are given by injection, such as Kisunla for Alzheimer’s disease and Dupixent. (iStock)

14. Zunveil – New drugs: Alzheimer’s disease

15. Yorvipat – New drugs: hypoparathyroidism (low levels of parathyroid hormone)

For more health articles visit www.foxnews.com/health

16. Nephi – New medicines: Heavy allergic reactions

17. FluMist – Additional use: self-administration or administration by a guardian

CLICK HERE TO SUBSCRIBE TO OUR HEALTH NEWSLETTER

18. Kobenfi – New drugs: Schizophrenia

19. Dupixent – Additional use: COPD

a woman uses a nasal spray in her bedroom

Many of the newly approved drugs are nasal sprays, such as FluMist, a nasal spray vaccine that helps prevent the flu, and Neffy, which is used to treat life-threatening allergic reactions. (iStock)

In a disclaimer, GoodRx noted that the list was created by prioritizing “first-in-class drugs and vaccines that are expected to have a significant impact on human health.”

“This was determined by either the number of lives affected or the expected degree of impact on future recipients of the medication,” the company wrote.

“We also prioritized drugs with efficacy or safety data that were demonstrably superior to other drugs recommended by clinical treatment guidelines or major medical organizations.”

CLICK HERE TO GET THE FOX NEWS PROGRAM

Fox News Digital has reached out to GoodRx for comment.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *